Pancreatic Cancer Research

ResearcherPennsylvania State UniversityNo recent work listed

Gail L. Matters

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8613-8649; OpenAlex author ID A5024301218. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
27
Papers, trials and grants by year

2012: 2 papers · 2013: 1 paper · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 2 papers

Papers 12

  1. Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. Last author DOI 10.1371/journal.pone.0206759↗
  2. Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer. Co-author DOI 10.3390/biomedicines6020065↗
  3. Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic ca… Co-author DOI 10.1016/j.nano.2017.06.017↗
  4. A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1089/nat.2016.0621↗
  5. "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma. First author DOI 10.1371/journal.pone.0184451↗
  6. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression. Co-author DOI 10.1093/hmg/ddw300↗
  7. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. Co-author DOI 10.1097/mpa.0000000000000263↗
  8. Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. Co-author DOI 10.1007/s10620-014-3201-8↗
  9. Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Last author DOI 10.1097/mpa.0000000000000194↗
  10. A Speculative Role for Stromal Gastrin Signaling in Development and Dissemination of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4172/2165-7092.s4-003↗
  11. Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis. First author DOI 10.1152/ajpgi.00460.2011↗
  12. A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer. Co-author DOI 10.4161/cbt.13.3.18698↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jill Palmer Smith · 8 shared papers, 2012–2017 · strength 0.37
  2. Gary A. Clawson · 5 shared papers, 2013–2018 · strength 0.34
  3. Thomas Abraham · 4 shared papers, 2017–2018 · strength 0.26
  4. Mark A. Kester · 4 shared papers, 2014–2018 · strength 0.25
  5. Samuel S. Linton · 3 shared papers, 2017–2018 · strength 0.21
  6. John F. Harms · 2 shared papers, 2012–2018 · strength 0.20
  7. Todd E. Fox · 2 shared papers, 2017–2018 · strength 0.14
  8. James H. Adair · 2 shared papers, 2017 · strength 0.12
  9. Welley Siu Loc · 2 shared papers, 2017 · strength 0.12
  10. Kristin K. Fino · 2 shared papers, 2012 · strength 0.07
  11. Joyce Y. Wong · 1 shared paper, 2017 · strength 0.06
  12. Randall E. Brand · 1 shared paper, 2015 · strength 0.06
  13. Marsha L. Frazier · 1 shared paper, 2015 · strength 0.06
  14. David Clement Whitcomb · 1 shared paper, 2015 · strength 0.06
  15. Qing Zhong · 1 shared paper, 2014 · strength 0.04
  16. Sara H. Olson · 1 shared paper, 2016 · strength 0.04
  17. Jason W. Hoskins · 1 shared paper, 2016 · strength 0.04
  18. Mingfeng Zhang · 1 shared paper, 2016 · strength 0.04
  19. Hemang M. Parikh · 1 shared paper, 2016 · strength 0.04
  20. Jinping Jia · 1 shared paper, 2016 · strength 0.04
  21. Rachael Z. Stolzenberg‐Solomon · 1 shared paper, 2016 · strength 0.04
  22. Robert C. Kurtz · 1 shared paper, 2016 · strength 0.04
  23. Alison P. Klein · 1 shared paper, 2016 · strength 0.04
  24. Brian Matthew Wolpin · 1 shared paper, 2016 · strength 0.04
  25. Laufey Thora Amundadottir · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.